|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02407 GAUSH MEDITECH
Nominal 
9.110 +0.220 (+2.475%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 1,428,397 | 1.576% | 1,406,238 | 1,253,785 | 1,298,218 | 962,075 |
| Cost of Sales | (765,008) | 7.048% | (714,638) | (628,447) | (688,747) | (525,898) |
| Gross Profit | 663,389 | -4.079% | 691,600 | 625,338 | 609,471 | 436,177 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (307,426) | (375,606) | (64,631) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 155,287 | -37.317% | 247,735 | (275,094) | (137,964) | 149,155 | |
| Taxation | (66,764) | -10.768% | (74,821) | (77,618) | (53,607) | (50,617) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 3,871 | 535.632% | 609 | 3,093 | 1,124 | 829 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 92,394 | -46.754% | 173,523 | (349,619) | (190,447) | 99,367 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 33,534 | -23.833% | 44,027 | 38,007 | 81,505 | (52) |
| Depreciation & Amortisation | 81,943 | 7.867% | 75,967 | 65,748 | 60,060 | 12,333 |
| Directors' Emoluments | 5,548 | -4.575% | 5,814 | 4,646 | 4,463 | 4,633 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 63.000 | -46.154% | 117.000 | -361.000 | -199.000 | -- |
| DPS (cts) | 27.688 | -- | 99.773 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | 43.950% | -- | 85.276% | -- | -- | -- |
| Cash flow per share ($) | 0.729 | -- | 1.683 | 2.418 | 1.716 | -- |
| NBV per share ($) | 10.651 | -- | 11.357 | 9.934 | -- | -- |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 37,974 |
| %Change | 33.364% |
| EPS / (LPS) | RMB 0.260 |
| NBV Per Share (¥) | RMB 11.248 |